KP Tissue Inc. (TSE:KPT – Get Free Report) reached a new 52-week high on Thursday . The stock traded as high as C$10.68 and last traded at C$10.68, with a volume of 32069 shares traded. The stock had previously closed at C$10.68.
Wall Street Analysts Forecast Growth
A number of equities analysts recently commented on the company. Canadian Imperial Bank of Commerce upped their target price on KP Tissue from C$10.50 to C$11.00 in a report on Friday, November 14th. National Bank Financial boosted their price objective on shares of KP Tissue from C$10.00 to C$11.00 and gave the company a “sector perform” rating in a research report on Monday, February 2nd. Three research analysts have rated the stock with a Hold rating, Based on data from MarketBeat.com, KP Tissue currently has a consensus rating of “Hold” and a consensus target price of C$10.25.
Read Our Latest Stock Analysis on KPT
KP Tissue Trading Up 0.4%
KP Tissue (TSE:KPT – Get Free Report) last issued its quarterly earnings results on Wednesday, February 18th. The company reported C$0.26 earnings per share (EPS) for the quarter. As a group, sell-side analysts forecast that KP Tissue Inc. will post 0.4398964 earnings per share for the current year.
Insider Transactions at KP Tissue
In other news, Director Michel Manseau sold 3,000 shares of the stock in a transaction on Tuesday, December 16th. The stock was sold at an average price of C$10.41, for a total transaction of C$31,230.00. Corporate insiders own 0.14% of the company’s stock.
About KP Tissue
KP Tissue Inc operates as a holding company. The firm produces, distributes, markets, and sells a range of disposable tissue products in North America. It offers bathroom and facial tissues, paper towels, paper towels, and napkins, as well as disposable wiping products and washroom dispensing systems.
Further Reading
- Five stocks we like better than KP Tissue
- The gold chart Wall Street is terrified of…
- Buy this Gold Stock Before May 2026
- What a Former CIA Agent Knows About the Coming Collapse
- This $15 Stock Could Go Down as the #1 Stock of 2026
- Unlocked: Elon Musk’s Next Big IPO
Receive News & Ratings for KP Tissue Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for KP Tissue and related companies with MarketBeat.com's FREE daily email newsletter.
